Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.36.18EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.32EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.59EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.67EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.277EWon-ECACACAATCGATGCGCAGTA20502636526346R-2361.24South Korea
AY.28 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.272EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.371EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AA.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.353EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.407EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AA.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.160.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.47EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.182EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.218EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.12.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
A.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.22 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.128EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.36.33EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.405EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.296EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.412EWon-ECACACAATCGATGCGCAGTA20502636526346R-1441.38South Korea
AC.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.27EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.421EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.364EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.82EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.61EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.47EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.38EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.251EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
A.2.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.288EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.249EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.378EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.97EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.439EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.408EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.256EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Q.7 (Alpha)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.460EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.262EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBUEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.351.5 (Beta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FZ.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.9.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used